Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001
(2001; 6 pages) [French] [Spanish] Voir le document au format PDF
Abrégé
In joining the WTO, Members adhere to 18 specific agreements annexed to the Agreement establishing the WTO. They cannot choose to be party to some agreements but not others (with the exception of a few “plurilateral” agreements that are not obligatory). Of greatest relevance to the health sector are: the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS); the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS); the Agreement on Technical Barriers to Trade (TBT); the General Agreement on Tariffs and Trade (GATT); and the General Agreement on Trade in Services (GATS). Of these agreements, TRIPS is expected to have the greatest impact on the pharmaceutical sector. The TBT Agreement should be of particular concern to producing countries, since its implementation may affect export markets...
Table des matières
Afficher le documentA new era in global trade
Afficher le documentKey requirements of the TRIPS Agreement
Afficher le documentPublic health and TRIPS
Afficher le documentEvaluating impacts of trade agreements
Afficher le documentWHO perspectives on access to drugs
Afficher le documentFurther reading
Afficher le documentContacts at WHO Headquarters:
 

Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001

WHO/EDM/2001.2
Original: English
Distr.: General

No. 3 March 2001
World Health Organization
Geneva

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 7 octobre 2014